H. Fernandez

ORCID: 0000-0002-6463-1018 · 51 papers in corpus · active 1999-2025

Study types

  • article 38
  • review 9
  • editorial 2
  • book-chapter 1
  • preprint 1

Condition tags

  • mesh:D004715 19
  • endometriosis 14
  • adenomyosis 9
  • mesh:D017699 7
  • mesh:D004414 5
  • infertility 5
  • dysmenorrhea 3
  • dyspareunia 2
  • mesh:D004412 2
  • chronic_pelvic_pain 1
article 2025
Validation of a Saliva Micro–RNA Signature for Endometriosis
NEJM evidence ·doi:10.1056/evidoa2400195

BACKGROUND: Diagnosis of endometriosis is a challenge. The recent development of a saliva-based micro-ribonucleic acid (miRNA) signature for the diagnosis of endometriosis may enable a timelier and less invasive approach, but this requires …

article 2024
12493 Treatment Versus Sham Double-Blind Efficacy Study of Robotic HIFU Treatment of Patients With Symptomatic Rectal Endometriosis
·doi:10.1016/j.jmig.2024.09.1015
review 2024
Clues to revising the conventional diagnostic algorithm for endometriosis
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.15840

Endometriosis is a complex gynecologic disorder characterized primarily by symptoms of pelvic pain, infertility, and altered quality of life. National and international guidelines highlight the diagnostic difficulties and lack of conclusive…

preprint 2024
Efficiency and Side Effects of Vulvovaginal Radiofrequency in Female Genitourinary Disorders: An Observational Study
·doi:10.2139/ssrn.4915068
article 2024
Evaluating the safety of high-intensity focused ultrasound treatment for rectal endometriosis: results from a French prospective multicentre study including 60 patients
Human Reproduction ·doi:10.1093/humrep/deae127

STUDY QUESTION: Is increasing the intensity of high-intensity focused ultrasound (HIFU) by 30% in the treatment of rectal endometriosis a safe procedure? SUMMARY ANSWER: This study demonstrates the safety of a 30% increase in the intensity …

article 2023
Adenomiosis: diagnóstico
·doi:10.1016/s1283-081x(23)47721-1
article 2023
Update on the management of endometriosis-associated pain in France
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102664
article 2023
Validation of a Salivary miRNA Signature of Endometriosis — Interim Data
NEJM evidence ·doi:10.1056/evidoa2200282

BACKGROUND: The discovery of a saliva-based micro–ribonucleic acid (miRNA) signature for endometriosis in 2022 opened up new perspectives for early and noninvasive diagnosis of the disease. The 109-miRNA saliva signature is the product of m…

article 2022
8142 Diagnostic Accuracy Study of Sonography in Adenomyosis: A Study in Current Practice
·doi:10.1016/j.jmig.2022.09.375
article 2020
Florid Cystic Endosalpingiosis and Adenomyosis of the Uterus Mimicking Malignancy
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2020.08.011
article 2020
Ulipristal acetate use in adenomyosis: A randomized controlled trial
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2020.101978
article 2019
1953 Ulipristal Acetate for Adenomyosis: A Multicenter Randomized Trial
·doi:10.1016/j.jmig.2019.09.192
article 2019
Endosearch: The International Clinical Trial to Test a Cluster of Biomarkers to Diagnose Endometriosis
·doi:10.1016/j.jmig.2019.09.755
article 2018
ENDOSEARCH the First European and North American International Clinical Trial Granted by the European Union Testing a Cluster of Biomarkers for the Diagnosis and Prognosis of Endometriosis
·doi:10.1016/j.jmig.2018.09.041
article 2018
Management of endometriosis
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2018.06.003
review 2018
[New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines]
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.009

OBJECTIVE: The objective of this work is to evaluate the place of new treatments in the management of endometriosis outside the context of infertility. METHODS: A review of the literature was conducted by consulting Medline data until July…

article 2018
Prise en charge de l’endométriose : recommandations pour la pratique clinique CNGOF-HAS (texte court)
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.027
review 2018
Traitement médical de l’endométriose douloureuse chez l’adolescente, RPC Endométriose CNGOF-HAS
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.029
review 2018
Traitement médical de l’endométriose douloureuse sans infertilité, RPC Endométriose CNGOF-HAS
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.028
review 2018
Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.011
book-chapter 2017
Cystic Adenomyosis: Place of Hysteroscopic Approach
·doi:10.1007/978-3-319-57559-9_44
article 2017
Hospital Burden 18 Months after Surgical Treatment of Functional Menorrhagia in France
·doi:10.1016/j.jval.2017.08.693
article 2015
Adenomiosis: tratamiento
·doi:10.1016/s1283-081x(15)72833-x
article 2015
Analyse des traitements chirurgicaux conservateurs des pathologies de l’endomètre en France de 2008 à 2010 dans les établissements de santé. Analyse des données du programme médicalisé des systèmes d’information (PMSI)
·doi:10.1016/j.jgyn.2015.01.009
review 2015
[Treatment of adenomyosis (excluding pregnancy project)]
Gynecologie, obstetrique & fertilite ·doi:10.1016/j.gyobfe.2015.03.016

In this review we aimed to update the possibilities of adenomyosis treatment in women excluding those with a desire for pregnancy. Adenomyosis is defined as the presence of endometrial tissue within the myometrium and frequently underestima…